News in other languages: Safe S.A.

06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

More news

Managers and Directors: Safe S.A.

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

More insiders

Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Deutsche Boerse AG Other stock markets 02:05:11 2026-07-01 EDT			5-day change	1st Jan Change
0.4900 ^EUR	-2.00%		0.00%	-75.50%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 146K 119K 109K 205K 13.94M 210K 1.41M 551K 6.94M 549K 537K 23.88M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.17M 12.35M 11.35M 21.3M 1.45B 21.82M 146M 57.23M 720M 56.95M 55.73M 2.48B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe S.A. Stock Deutsche Boerse AG

Stocks

OR9

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news : Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Safe S.A.

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

1 day	-2.00%
Current month	-2.00%
1 month	+8.89%
3 months	-26.87%
6 months	-35.53%
Current year	-75.50%

1 month	0.49	0.5
Current year	0.4	1.65
1 year	0.4	2
3 years	0.1	480,048
5 years	0.1	1,000,000
10 years	0.1	1,000,000

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	-2.00%	0.00%	-	-	145K
STRYKER CORPORATION	+1.63%	+11.97%	-12.09%	+24.47%	133B
SMITH & NEPHEW PLC	+1.21%	+8.00%	+3.71%	+2.19%	13.43B
GLAUKOS CORPORATION	+6.83%	+5.60%	+70.31%	+111.74%	8.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.27%	+4.27%	-44.88%	-69.82%	4.71B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.18%	+0.25%	+0.54%	+38.53%	2.63B
ENOVIS CORPORATION	+2.51%	+11.66%	+10.76%	-52.17%	1.7B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.47%	+1.44%	-15.85%	-23.38%	1.62B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.35%	+3.25%	-24.63%	-33.29%	1.61B
Average	+1.88%	+3.14%	-1.51%	-0.22%	20.93B
Weighted average by Cap.	+1.83%	+4.99%	-7.10%	+23.09%

	2024	2025
Net sales	5.04M 5.78M 4.7M 4.32M 8.11M 551M 8.31M 55.75M 21.79M 274M 21.68M 21.22M 944M	5.36M 6.15M 5M 4.6M 8.63M 586M 8.84M 59.32M 23.18M 292M 23.07M 22.58M 1B
Net income	-1.93B -2.21B -1.8B -1.65B -3.1B -211B -3.18B -21.34B -8.34B -105B -8.3B -8.12B -361B	-4.67M -5.36M -4.36M -4.01M -7.52M -511M -7.7M -51.69M -20.2M -254M -20.11M -19.67M -875M
Net Debt	11.47M 13.15M 10.7M 9.83M 18.46M 1.25B 18.91M 127M 49.58M 624M 49.34M 48.28M 2.15B	13.11M 15.03M 12.23M 11.24M 21.1M 1.43B 21.61M 145M 56.67M 713M 56.4M 55.19M 2.46B